id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2067776,0d03fdf2-7eae-4e56-99c7-952aa5b720d9,Q4,OREGON HEALTH & SCIENCE UNIVERSITY,30291,OREGON HEALTH & SCIENCE UNIVERSITY,2017,fourth_quarter,BUD,"FDA regulation of mitochondrial replacement therapy Sections 736 in ""Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017"" (HR 5054/ S.2956); FY2017 funding for Zika: ""Zika Response Appropriations Act, 2016"" (HR5243), Division B in ""Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017"" (HR 2577). FY2017 and FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; HR 244, Consolidated Appropriations Act 2017 (P.L. 115-31); health and science related funding issues. HR 3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; HJ Res. 123, Making further continuing appropriations for fiscal year 2018, and for other purposes (PL 115-90); HR 1370, Further Additional Continuing Appropriations Act, 2018 (PL 115-96); health and science related funding issues.","HOUSE OF REPRESENTATIVES,SENATE",,80000,0,0,2018-01-18T13:30:17.057000-05:00